A multiplex analysis is particularly useful for NSCLC due to often limited amount of available tissue and the increasing number of predictive markers beyond EGFR (including BRAF, ERBB2 and MET) [13,14,15]. Here, EGFR is linked to non-small cell lung carcinoma.